[CoMeD] The 'Anything but Mercury' Realities

[Guest guest]

  

The truth is

that Thimerosal is still found in several vaccines marketed

in the

USA at a less-than-preservative

level and, currently, all of the

multi-dose formulations

of the US-licensed inactivated-influenza

vaccines produced by

Sanofi, Novartis, CSL

(Merck), and

GlaxoKline are still Thimerosal-preserved doses

that account for

more than 50% of the

available doses.

   In

addition, in the developing countries, the DTP, Hib, Hep

B, DT,

TT vaccines and

combinations of these

components are still Thimerosal-preserved.

   Yet,

this researcher continually finds that the most frequent

LIE in

any mainstream

media piece that claims that

there is no link between the level of

Thimerosal-exposure

and the risk of serious adverse reactions

including death and permanent disability or

chronic disease is:

     'Thimerosal

was removed from … vaccines in 2000, 2001, 2002, or

some other year'.

   Further,

when misleadingly attempting to

offer “anything but mercury”

alternative

to the growing epidemics of chronic

disease these Establishment articles invariably

focus

on “autism spectrum disorders”, often simply

called “autism”, which, because

these are symptom-based

diagnoses, the causative links are harder

to prove.

   However,

the reality is that the increase in injected-Thimerosal

exposure

is probably

the most significant causal factor

in the growing epidemics of childhood chronic

diseases

that were non-existent or rare prior to the late 1970s.

   The

attached article,

     “The

‘Anything but Mercury’ Realities”,

addresses the reality that,

in the USA and the developing countries where

Thimerosal-preserved

vaccines are still being illegally

or improperly used in vaccines given to

pregnant women

(without the required reproductive

toxicity studies to justify such use in

pregnant women)

and developing children, Thimerosal is a

major causal factor in all of these epidemic

increases in childhood chronic diseases,

including, but not limited to, childhood neuro-

developmental

and developmental disorders, childhood asthma,

childhood obesity, childhood

allergies,

childhood type 2 diabetes, severe childhood

gastrointestinal

disorders, childhood

muscle weakness

and incoordination, and childhood Kawasaki’s syndrome.

   If

injected Thimerosal had been proven to be

“safe” for pregnant women

and developing

children, then, at a minimum, there

would be published toxicological no-effect

levels for

injected Thimerosal.

   In

toxicology, these levels are called the

NOAELs (no observed

adverse-effect levels) for

the chemical.

   For

example, the NOAEL for injected

Thimerosal in developing children would

be expressed

as:  NOAEL

inj. Thimerosal, developing

children.

   For those

substances that are rapidly metabolized into non-toxic,

non-accumulative end-

point metabolites, NOAELs are typically

expressed in terms of the mass of the substance per

kilogram of body mass in the exposed individuals per

day (mass of substance/kg/day).

   For those

substances whose metabolic products are

bioaccumulatively toxic

where the half-

life for the end-metabolite is a

significant percentage of the human’s life span (e.g., a

half-life of 10 to 20 years when the human life-span

is 60-80 years [or a half-life of 12.5%

to 33% of the

human life-span], the appropriate units for a

NOAEL for such chemicals is

simply mass of substance per kilogram of

body mass (mass of substance/kg).

   To

determine a valid NOAEL for a substance,

the appropriate chronic toxicity

studies in

an animal having a well-defined

relative toxicity to human toxicity are conducted at

various

exposure levels starting from below the

level at which any acute toxicity effect is

observed

that mimic human exposure and proceeding downward in

a decreasing concentration pattern

to a level well below

that where any long-term toxic effects will be

observed along with a

control, where, for

injected substances, the test control

is:

 a.  A sterile,

pH-balanced, isotonic saline injection of

the same volume as the test

     substance or

 b.  A

solution prepared as in “a.” with

glucose added at

the level of the toxic substance.

   Then,

the test animals are repeatedly dosed at

the selected levels and their

weight and

health monitored for a significant portion

of their nominal lifetimes (e.g., at least a year

in

rats that typically live for about 2 years).

   The

dosing is then discontinued and the

health of the animals tracked for

some additional

period or until the animal dies and, at

the end of the study, all of the remaining animals

are sacrificed and

autopsied – ideally with appropriate tissue-slide

comparisons between the

test animals and the control animals.

   From

the results of the autopsies, the

adverse effects and their magnitudes are

computed

at each test level.

   By

plotting the results against the exposure

levels, correlated adverse effects

are

identified and their “no effect” levels

computed.

   From

these computations, the NOAEL levels

for the test substance are

computed.

   Using

the recognized inter-species toxicity factors for the

test animals, which is a divisor

of 10 for the NOAEL in rats to compute the average NOAEL

toxicity level in humans.

   Then, the computed

NOAEL for injected Thimerosal in humans is divided by 10

to

estimate

the general human NOAEL and, unless

the study included the appropriate testing of

the

neonatal animals, the result is again divided by

a factor of 10 to obtain the specific

developing human NOAEL value. [Thus, the NOAEL for

injected Thimerosal in developing humans is

the NOAEL for injected Thimerosal in rats divided by 1000.]

   When

such values are found, then the

appropriate NOAEL is the “safe” level

for exposure to

that chemical.

   However,

absent the applicable established NOAELs for a

substance,

especially one whose

end-point metabolite is a

bioaccumulative poison, there is NO proven “safe” level

for

that

substance.

   Since:

a)

Thimerosal, a highly toxic, bioaccumulative mercury

poison, is the substance,

Thimerosal is injected in a vaccine

formulation, and c)

developing humans are the most

sensitive general group, the critical NOAEL is: NOAEL injected

Thimerosal, developing human.

   With

these realities in mind, this scientist

provides his view of the “anything

but mercury”

realities in the attached file.

 

   If

your provider does not allow attachments,

you can access the file at:

 http://dr-king.com/docs/20120514_The_AnythingButMercury_Realities_b.pdf

or:

 http://mercury-freedrugs.org/docs/20120514_The_AnythingButMercury_Realities_b.pdf

 

   If you

need a Word “doc” file, please send an e-mail with

“TABMR” in the

subject line

and the reason for your request in the body of the

e-mail.

 

Respectfully,

 

G. King, PhD

http://www.dr-king.com

 

 

CoMeD Science Advisor

& Secretary

 

PS: The article,

    "'Falsus

in Unum, Falsus in Omnibus' -- A Thimerosal-preserved

Vaccine Conundrum" (31

March 2012; 4 pages)"”

    http://dr-king.com/docs/20120331_FalsusInUnoFalsusInOmnibusAThimerosalpreservedVaccineConundrum_b.pdf

    is now

available on the CoMeD website as well as dr-king.com in case

you missed it.